Merck Sharp & Dohme’s
MDS is a research-intensive biopharmaceutical company that develops important medicines and vaccines.
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. Aster DM Healthcare names new Aster Sanad Hospital CEO 2. Leading medical providers, innovations lauded at Healthcare Asia Awards 2025 3. King Khalid Hospital Alkharj wins double honours at Healthcare Asia Awards 2025 4. Capitol Medical Center wins at Healthcare Asia Awards 2025 for paediatric primary healthcare programme 5. Singapore researchers develop AI-powered 3D imaging for skin cancer mgmtResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
The company received the Technology Innovation of the Year - Malaysia and the Smart Hospital Initiative of the Year - Malaysia wins.
